Clinical trials sponsored by Philogen S.p.A.

Phase breakdown

Conditions studied

Recruiting trials led by Philogen S.p.A.

• A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer
  NCT07600554 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 2 locations
• A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
  NCT07245992 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
  NCT03567889 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
  NCT06284590 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations

Common questions

How many trials is Philogen S.p.A. recruiting for?

Philogen S.p.A. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.